AEGiS-UNAIDS: 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention opens in Sydney UNAIDSImportant note: Information in this article was accurate in 2007. The state of the art may have changed since the publication date.
Click here to return to UNAIDS main menu
DonateNow
Print this Article


4th IAS Conference on HIV Pathogenesis, Treatment and Prevention opens in Sydney

UNAIDS - July 21, 2007


The Australian Society for HIV Medicine and the International AIDS Society are hosting the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention in Sydney, Australia from 22-25 July 2007.

Over 5000 delegates are expected to attend the conference which features the latest developments in HIV biology, pathogenesis, treatment and prevention science.

Held every two years, the conference is an opportunity for leading scientists, clinicians, public health experts and community leaders to examine the latest developments in HIV-related research, and to explore how scientific advances can inform the global response to AIDS.

This is the first IAS conference encompassing "Biomedical Prevention" in addition to Pathogenesis and Treatment, in line with the decision to include biomedical prevention made during the 2005 meeting in Rio de Janeiro.

The biomedical prevention track will focus on strategies for preventing HIV transmission that have a biomedical basis, such as vaccines, microbicides, chemoprophylaxis and substitution therapy for drug dependence.

Deputy Executive Director of Programmes at UNAIDS, Michel Sibide, will participate in events around treatment, sustainability in the era of universal access, the TB/HIV co-epidemic and men who have sex with men in Asia. Chief Scientific Adviser Dr Cate Hankins will be launching new guidelines on ethics and good practice in trials.

Conference web site: http://www.ias2007.org/

International AIDS Society: http://www.iasociety.org/


070721
UN070711


Copyright © 2007 - Joint United Nations Programme on HIV/AIDS (UNAIDS). All rights reserved. UNAIDS articles, which are not formal publications of UNAIDS, may be freely reviewed, quoted, reproduced or translated, in part or in full, provided the source is acknowledged. The documents may not be sold or used in conjunction with commercial purposes without prior written approval from UNAIDS (contact: UNAIDS Information Centre).

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .